» Articles » PMID: 32093744

Assessment of Developmental Neurotoxicity Induced by Chemical Mixtures Using an Adverse Outcome Pathway Concept

Overview
Journal Environ Health
Publisher Biomed Central
Date 2020 Feb 26
PMID 32093744
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In light of the vulnerability of the developing brain, mixture risk assessment (MRA) for the evaluation of developmental neurotoxicity (DNT) should be implemented, since infants and children are co-exposed to more than one chemical at a time. One possible approach to tackle MRA could be to cluster DNT chemicals in a mixture on the basis of their mode of action (MoA) into 'similar' and 'dissimilar', but still contributing to the same adverse outcome, and anchor DNT assays to common key events (CKEs) identified in DNT-specific adverse outcome pathways (AOPs). Moreover, the use of human in vitro models, such as induced pluripotent stem cell (hiPSC)-derived neuronal and glial cultures would enable mechanistic understanding of chemically-induced adverse effects, avoiding species extrapolation.

Methods: HiPSC-derived neural progenitors differentiated into mixed cultures of neurons and astrocytes were used to assess the effects of acute (3 days) and repeated dose (14 days) treatments with single chemicals and in mixtures belonging to different classes (i.e., lead(II) chloride and methylmercury chloride (heavy metals), chlorpyrifos (pesticide), bisphenol A (organic compound and endocrine disrupter), valproic acid (drug), and PCB138 (persistent organic pollutant and endocrine disrupter), which are associated with cognitive deficits, including learning and memory impairment in children. Selected chemicals were grouped based on their mode of action (MoA) into 'similar' and 'dissimilar' MoA compounds and their effects on synaptogenesis, neurite outgrowth, and brain derived neurotrophic factor (BDNF) protein levels, identified as CKEs in currently available AOPs relevant to DNT, were evaluated by immunocytochemistry and high content imaging analysis.

Results: Chemicals working through similar MoA (i.e., alterations of BDNF levels), at non-cytotoxic (IC/100), very low toxic (IC), or moderately toxic (IC) concentrations, induce DNT effects in mixtures, as shown by increased number of neurons, impairment of neurite outgrowth and synaptogenesis (the most sensitive endpoint as confirmed by mathematical modelling) and increase of BDNF levels, to a certain extent reproducing autism-like cellular changes observed in the brain of autistic children.

Conclusions: Our findings suggest that the use of human iPSC-derived mixed neuronal/glial cultures applied to a battery of assays anchored to key events of an AOP network represents a valuable approach to identify mixtures of chemicals with potential to cause learning and memory impairment in children.

Citing Articles

Evaluation of developmental toxicity of chlorpyrifos through new approach methodologies: a systematic review.

Coppola L, Lori G, Tait S, Sogorb M, Estevan C Arch Toxicol. 2025; 99(3):935-981.

PMID: 39869190 PMC: 11821739. DOI: 10.1007/s00204-024-03945-6.


Mechanisms of Neurotoxicity of Organophosphate Pesticides and Their Relation to Neurological Disorders.

Chen Y, Yang Z, Nian B, Yu C, Maimaiti D, Chai M Neuropsychiatr Dis Treat. 2024; 20:2237-2254.

PMID: 39588175 PMC: 11587806. DOI: 10.2147/NDT.S479757.


Associating prenatal phthalate exposure with childhood autistic traits: Investigating potential adverse outcome pathways and the modifying effects of maternal vitamin D.

Gao H, Zhang C, Zhu B, Geng M, Tong J, Zhan Z Eco Environ Health. 2024; 3(4):425-435.

PMID: 39559191 PMC: 11570402. DOI: 10.1016/j.eehl.2024.01.007.


Stem cell-based approaches for developmental neurotoxicity testing.

Ku J, Asuri P Front Toxicol. 2024; 6:1402630.

PMID: 39238878 PMC: 11374538. DOI: 10.3389/ftox.2024.1402630.


The Progress in Molecular Transport and Therapeutic Development in Human Blood-Brain Barrier Models in Neurological Disorders.

Korszun-Karbowniczak J, Krysiak Z, Saluk J, Niemcewicz M, Zdanowski R Cell Mol Neurobiol. 2024; 44(1):34.

PMID: 38627312 PMC: 11021242. DOI: 10.1007/s10571-024-01473-6.


References
1.
Long Z, Zhao L, Jiang R, Wang K, Luo S, Zheng M . Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model. CNS Neurosci Ther. 2015; 21(11):887-97. PMC: 6493017. DOI: 10.1111/cns.12445. View

2.
Harrill J, Robinette B, Mundy W . Use of high content image analysis to detect chemical-induced changes in synaptogenesis in vitro. Toxicol In Vitro. 2010; 25(1):368-87. DOI: 10.1016/j.tiv.2010.10.011. View

3.
Gassowska M, Baranowska-Bosiacka I, Moczydlowska J, Frontczak-Baniewicz M, Gewartowska M, Struzynska L . Perinatal exposure to lead (Pb) induces ultrastructural and molecular alterations in synapses of rat offspring. Toxicology. 2016; 373:13-29. DOI: 10.1016/j.tox.2016.10.014. View

4.
Lyng G, Snyder-Keller A, Seegal R . Polychlorinated biphenyl-induced neurotoxicity in organotypic cocultures of developing rat ventral mesencephalon and striatum. Toxicol Sci. 2007; 97(1):128-39. DOI: 10.1093/toxsci/kfm027. View

5.
Imamura L, Kurashina K, Kawahira T, Omoteno M, Tsuda M . Additional repression of activity-dependent c-fos and BDNF mRNA expression by lipophilic compounds accompanying a decrease in Ca2+ influx into neurons. Neurotoxicology. 2004; 26(1):17-25. DOI: 10.1016/j.neuro.2004.07.008. View